Anchoring Hepatic Gene Expression with Development of Fibrosis and Neoplasia in a Toxicant-induced Fish Model of Liver Injury

Toxicologic Pathology

Volumn 41, Issue 5, 2013, Pages 744-760

  Van Wettere, Arnaud J ^a   Law, J Mac ^a   Hinton, David E ^b   Kullman, Seth W ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

dimethylnitrosamine; fibrosis; gene expression; liver; medaka; neoplasia; Oryzias latipes

Indexed keywords

BETA CATENIN; COLLAGENASE 3; DIMETHYLNITROSAMINE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL MATURATION; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CANCER; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER INJURY; MALE; NONHUMAN; ORYZIAS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STELLATE CELL; UPREGULATION;

DIMETHYLNITROSAMINE; FIBROSIS; GENE EXPRESSION.; LIVER; MEDAKA; NEOPLASIA; ORYZIAS LATIPES;

ANIMALS; DIMETHYLNITROSAMINE; DISEASE MODELS, ANIMAL; DRUG-INDUCED LIVER INJURY; FEMALE; FISH PROTEINS; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRRHOSIS; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; ORYZIAS; PHENOTYPE;

ORYZIAS LATIPES; ORYZIINAE;

EID: 84879487447     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623312464308     Document Type: Article

References (77)

1. Abou-Shady M. Baer H. U. Friess H. Berberat P. Zimmermann A. Graber H. Gold L. I. Korc M. Buchler M. W. (1999). Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma. Am J Surg 177, 209–15.
2. Ala-Kokko L. Pihlajaniemi T. Myers J. C. Kivirikko K. I. Savolainen E. R. (1987). Gene expression of type I, III and IV collagens in hepatic fibrosis induced by dimethylnitrosamine in the rat. Biochem J 244, 75–79.
3. Boorman G. A. Botts S. Bunton T. E. Fournie J. W. Harshbarger J. C. Hawkins W. E. Hinton D. E. Jokinen M. P. Okihiro M. S. Wolfe M. J. (1997). Diagnostic criteria for degenerative, inflammatory, proliferative nonneoplastic and neoplastic liver lesions in Medaka (Oryzias latipes): Consensus of a national toxicology program pathology working group. Toxicol Pathol 25, 202–10.
4. Bunton T. E. (1995). Expression of actin and desmin in experimentally induced hepatic lesions and neoplasms from medaka (Oryzias latipes). Carcinogenesis 16, 1059–63.
5. Calabrese F. Valente M. Giacometti C. Pettenazzo E. Benvegnu L. Alberti A. Gatta A. Pontisso P. (2003). Parenchymal transforming growth factor beta-1: Its type II receptor and Smad signaling pathway correlate with inflammation and fibrosis in chronic liver disease of viral etiology. J Gastroenterol Hepatol 18, 1302–308.
6. Chantal H. (2000).Biliary epithelial cell response to cholestasis. J Hepatol 32, Supplement 2, 14–15.
7. Cheng J. H. She H. Han Y. P. Wang J. Xiong S. Asahina K. Tsukamoto H. (2008). Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis. Am J Physiol Gastrointest Liver Physiol 294, G39–49.
8. Chin G. S. Liu W. Peled Z. Lee T. Y. Steinbrech D. S. Hsu M. Longaker M. T. (2001). Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts. Plast Reconstr Surg 108, 423–29.
9. Cooke J. B. Hinton D. E. (1999). Promotion by 17β-estradiol and β-hexachlorocyclohexane of hepatocellular tumors in medaka, Oryzias latipes. Aquat Toxicol 45, 127–45.
10. Dykstra M. J. (1993). Manual of Applied Techniques for Biological Electron Microscopy. Plenum Press, New York, NY.
11. Flanders K. C. (2004). Smad3 as a mediator of the fibrotic response. Int J ExpPathol 85, 47–64.
12. George J. Rao K. R. Stern R. Chandrakasan G. (2001). Dimethylnitrosamine-induced liver injury in rats: The early deposition of collagen. Toxicology 156, 129–38.
13. Z., Gong, C.C.V., Koh, A.T., Nguyen, H., Zhan, Z., Li, S.H., Lam, J.M., Spitsbergen, A., Emelyanov, S., Parinov, The Zebrafish model for liver carcinogenesis, Molecular Genetics of Liver Neoplasia, Wang, X. W., Grisham, J. W., Thorgeirsson, S. S., Springer New York, New York, NY, (2011), 197-218
14. Gressner A. M. Weiskirchen R. Breitkopf K. Dooley S. (2002). Roles of TGF-beta in hepatic fibrosis. Front Biosci 7, 793–807.
15. Harada N. Oshima H. Katoh M. Tamai Y. Oshima M. Taketo M. M. (2004). Hepatocarcinogenesis in mice with beta-catenin and Ha-ras gene mutations. Cancer Res 64, 48–54.
16. Haramis A. P. Hurlstone A. van der Velden Y. Begthel H. van den Born M. Offerhaus G. J. Clevers H. C. (2006). Adenomatous polyposis coli-deficient zebrafish are susceptible to digestive tract neoplasia. EMBO Rep 7, 444–49.
17. Hardman R. C. Kullman S. W. Hinton D. E. (2008). Non invasive in vivo investigation of hepatobiliary structure and function in STII medaka (Oryzias latipes): Methodology and applications. Comp Hepatol 7, 7.
18. Hardman R. C. Volz D. C. Kullman S. W. Hinton D. E. (2007). An in vivo look at vertebrate liver architecture: three-dimensional reconstructions from medaka (Oryzias latipes). Anat Rec (Hoboken) 290, 770–82.
19. Hatanaka J. Doke N. Harada T. Aikawa T. Enomoto M. (1982). Usefulness and rapidity of screening for the toxicity and carcinogenicity of chemicals in medaka, Oryzias latipes. Jpn J Exp Med 52, 243–53.
20. Hautekeete M. L. Geerts A. (1997). The hepatic stellate (Ito) cell: Its role in human liver disease. Virchows Arch 430, 195–207.
21. Hemmann S. Graf J. Roderfeld M. Roeb E. (2007). Expression of MMPs and TIMPs in liver fibrosis — A systematic review with special emphasis on anti-fibrotic strategies. J Hepatol 46, 955–75.
22. Herbst H. Wege T. Milani S. Pellegrini G. Orzechowski H. D. Bechstein W. O. Neuhaus P. Gressner A. M. Schuppan D. (1997). Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis. Am J Pathol 150, 1647–59.
23. Hernandez-Gea V. Friedman S. L. (2010). Pathogenesis of liver fibrosis. Annu Rev Pathol 6, 456.
24. Heron M. Hoyert D. L. Murphy S. L. Xu J. Kochanek K. D. Tejada-Vera B. (2009). Deaths: Final data for 2006. Natl Vital Stat Rep 57, 1–134.
25. D.E., Hinton, R.C., Hardman, S.W., Kullman, J.M.M., Law, M.C., Schmale, R.B., Walter, R.N., Winn, J.A., Yoder, Aquatic animal model of human disease: Selected papers and recommendations from the 4th Conference, Comp Biochem Physiol C Toxicol Pharmacol, (2009), 149, 121-128
26. D.E., Hinton, H., Segner, D.D.T., Au, S.K., Kullman, R.C., Hardman, Liver Toxicity, The Toxicology of Fishes, Di Giulio, R. T., Hinton, D. E., CRC Press, Boca Raton, FL, (2008), 401
27. Hobbie K. R. Deangelo A. B. George M. H. Law J. M. (2011). Neoplastic and nonneoplastic liver lesions induced by dimethylnitrosamine in Japanese Medaka Fish. Vet Pathol 49, 372–85.
28. Hoenerhoff M. J. Pandiri A. R. Lahousse S. A. Hong H. H. Ton T. V. Masinde T. Auerbach S. S. Gerrish K. Bushel P. R. Shockley K. R. Peddada S. D. Sills R. C. (2011). Global gene expression profiling of spontaneous hepatocellular carcinoma in B6C3F1 mice: Similarities in the molecular landscape with human liver cancer. Toxicol Pathol 39, 678–99.
29. Hong S. W. Isono M. Chen S. Iglesias-De La Cruz M. C. Han D. C. Ziyadeh F. N. (2001). Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse. Am J Pathol 158, 1653–63.
30. Hyon M. Kwon E. Choi H. J. Kang B. (2011). Dimethylnitrosamine-induced liver fibrosis and recovery in NOD/SCID mice. J Vety Med Sci 73, 739–45.
31. Iredale J. P. Benyon R. C. Arthur M. J. Ferris W. F. Alcolado R. Winwood P. J. Clark N. Murphy G. (1996). Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology 24, 176–84.
32. Jakowlew S. B. Mead J. E. Danielpour D. Wu J. Roberts A. B. Fausto N. (1991). Transforming growth factor-beta (TGF-beta) isoforms in rat liver regeneration: Messenger RNA expression and activation of latent TGF-beta. Cell Regul 2, 535–48.
33. Jezequel A. M. Mancini R. Rinaldesi M. L. Macarri G. Venturini C. Orlandi F. (1987). A morphological study of the early stages of hepatic fibrosis induced by low doses of dimethylnitrosamine in the rat. J Hepatol 5, 174–81.
34. Kim Y. Sills R. C. Houle C. D. (2005). Overview of the molecular biology of hepatocellular neoplasms and hepatoblastomas of the mouse liver. Toxicol Pathol 33, 175–80.
35. Kim Y. D. Park C. H. Kim H. S. Choi S. K. Rew J. S. Kim D. Y. Koh Y. S. Jeung K. W. Lee K. H. Lee J. S. Juhng S. W. Lee J. H. (2008). Genetic alterations of Wnt signaling pathway-associated genes in hepatocellular carcinoma. J Gastroenterol Hepatol 23, 110–8.
36. Kiss A. Wang N. J. Xie J. P. Thorgeirsson S. S. (1997). Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met,TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas. Clin Cancer Res 3, 1059–66.
37. Kossakowska A. E. Edwards D. R. Lee S. S. Urbanski L. S. Stabbler A. L. Zhang C. L. Phillips B. W. Zhang Y. Urbanski S. J. (1998). Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis. Am J Pathol 153, 1895–902.
38. Kweon Y. O. Goodman Z. D. Dienstag J. L. Schiff E. R. Brown N. A. Burchardt E. Schoonhoven R. Brenner D. A. Fried M. W. (2001). Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B. J Hepatol 35, 749–55.
39. Lichtinghagen R. Bahr M. J. Wehmeier M. Michels D. Haberkorn C. I. Arndt B. Flemming P. Manns M. P. Boeker K. H. (2003). Expression and coordinated regulation of matrix metalloproteinases in chronic hepatitis C and hepatitis C virus-induced liver cirrhosis. Clin Sci (Lond) 105, 373–82.
40. Livak K. J. Schmittgen T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402–408.
41. Madtes D. K. Elston A. L. Kaback L. A. Clark J. G. (2001). Selective induction of tissue inhibitor of metalloproteinase-1 in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 24, 599–607.
42. Mamiya T. Yamazaki K. Masugi Y. Mori T. Effendi K. Du W. Hibi T. Tanabe M. Ueda M. Takayama T. Sakamoto M. (2010). Reduced transforming growth factor-beta receptor II expression in hepatocellular carcinoma correlates with intrahepatic metastasis. Lab Invest 90, 1339–45.
43. Matsuzaki K. (2009). Modulation of TGF-beta signaling during progression of chronic liver diseases. Front Biosci 14, 2923–34.
44. McDowell E. M. Trump B. F. (1976). Histologic fixatives suitable for diagnostic light and electron microscopy. Arch Pathol Lab Med 100, 405–14.
45. Menescal L. A. Schmidt C. Liedtke D. Schartl M. (2012). Liver hyperplasia after tamoxifen induction of Myc in a transgenic medaka model. Dis Model Mech. 5, 492–502.
46. Michalopoulos G. K. DeFrances M. C. (1997). Liver regeneration. Science 276, 60–66.
47. Milani S. Herbst H. Schuppan D. Stein H. Surrenti C. (1991). Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease. Am J Pathol 139, 1221–29.
48. Musch A. Rabe C. Paik M. D. Berna M. J. Schmitz V. Hoffmann P. Nischalke H. D. Sauerbruch T. Caselmann W. H. (2005). Altered expression of TGF-beta receptors in hepatocellular carcinoma–effects of a constitutively active TGF-beta type I receptor mutant. Digestion 71, 78–91.
49. Myung S. J. Yoon J. H. Gwak G. Y. Kim W. Lee J. H. Kim K. M. Shin C. S. Jang J. J. Lee S. H. Lee S. M. Lee H. S. (2007). Wnt signaling enhances the activation and survival of human hepatic stellate cells. FEBS Lett 581, 2954–58.
50. Nicholson M. L. Waller J. R. Bicknell G. R. (2002). Renal transplant fibrosis correlates with intragraft expression of tissue inhibitor of metalloproteinase messenger RNA. Br J Surg 89, 933–37.
51. Ohara F. Nii A. Sakiyama Y. Tsuchiya M. Ogawa S. (2007). Pathophysiological characteristics of dimethylnitrosamine-induced liver fibrosis in acute and chronic injury models: A possible contribution of KLF5 to fibrogenic responses. Dig Dis Sci 53, 2222–32.
52. Okihiro M. S. Hinton D. E. (1999). Progression of hepatic neoplasia in medaka (Oryzias latipes) exposed to diethylnitrosamine. Carcinogenesis 20, 933–40.
53. Okihiro M. S. Hinton D. E. (2000). Partial hepatectomy and bile duct ligation in rainbow trout (Oncorhynchus mykiss): Histologic, immunohistochemical and enzyme histochemical characterization of hepatic regeneration and biliary hyperplasia. Toxicol Pathol 28, 342–56.
54. Oster S. K. Ho C. S. Soucie E. L. Penn L. Z. (2002). The myc oncogene: Marvelously complex. Adv Cancer Res 84, 81–154.
55. Parkin D. M. Bray F. Ferlay J. Pisani P. (2001). Estimating the world cancer burden: Globocan 2000. Int J Cancer 94, 153–56.
56. Peto R. Gray R. Brantom P. Grasso P. (1991). Effects on 4080 rats of chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine: A detailed dose-response study. Cancer Res 51, 6415–51.
57. Postlethwait J. H. (2007). The zebrafish genome in context: Ohnologs gone missing. J ExpZool B Mol Dev Evol 308, 563–77.
58. Qi Z. Atsuchi N. Ooshima A. Takeshita A. Ueno H. (1999). Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat. Proc Natl Acad Sci U S A 96, 2345–49.
59. Roberts A. B. Tian F. Byfield S. D. Stuelten C. Ooshima A. Saika S. Flanders K. C. (2006). Smad3 is key to TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis. Cytokine Growth Factor Rev 17, 19–27.
60. Roth S. Gong W. Gressner A. M. (1998). Expression of different isoforms of TGF-beta and the latent TGF-beta binding protein (LTBP) by rat Kupffer cells. J Hepatol 29, 915–22.
61. Roulot D. Sevcsik A. M. Coste T. Strosberg A. D. Marullo S. (1999). Role of transforming growth factor beta type II receptor in hepatic fibrosis: Studies of human chronic hepatitis C and experimental fibrosis in rats. Hepatology 29, 1730–38.
62. Santoni-Rugiu E. Preisegger K. H. Kiss A. Audolfsson T. Shiota G. Schmidt E. V. Thorgeirsson S. S. (1996). Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model. Proc Natl Acad Sci U S A 93, 9577–82.
63. Schultze-Mosgau S. Wehrhan F. Rödel F. Amann K. Radespiel-Tröger M. Grabenbauer G. G. (2003). Transforming growth factor-β receptor-II up-regulation during wound healing in previously irradiated graft beds in vivo. Wound Repair Regen 11, 297–305.
64. Shackel N. A. McGuinness P. H. Abbott C. A. Gorrell M. D. McCaughan G. W. (2001). Identification of novel molecules and pathogenic pathways in primary biliary cirrhosis: cDNA array analysis of intrahepatic differential gene expression. Gut 49, 565–76.
65. Sherman M. (2010). Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Semin Liver Dis 30, 3–16.
66. Tada S. Nakamuta M. Enjoji M. Sugimoto R. Iwamoto H. Kato M. Nakashima Y. Nawata H. (2001). Pirfenidone inhibits dimethylnitrosamine-induced hepatic fibrosis in rats. Clin Exp Pharmacol Physiol 28, 522–27.
67. Tao L. H. Enzan H. Hayashi Y. Miyazaki E. Saibara T. Hiroi M. Toi M. Kuroda N. Naruse K. Jin Y. L. Guo L. M. (2000). Appearance of denuded hepatic stellate cells and their subsequent myofibroblast-like transformation during the early stage of biliary fibrosis in the rat. Med Electron Microsc 33, 217–30.
68. Teh S. J. Hinton D. E. (1998). Gender-specific growth and hepatic neoplasia in medaka (Oryzias latipes). Aquat Toxicol 41, 141–59.
69. Thompson M. D. Monga S. P. (2007). WNT/beta-catenin signaling in liver health and disease. Hepatology 45, 1298–305.
70. Thoolen B. Maronpot R. R. Harada T. Nyska A. Rousseaux C. Nolte T. Malarkey D. E. Kaufmann W. Kuttler K. Deschl U. Nakae D. Gregson R. Vinlove M. P. Brix A. E. Singh B. Belpoggi F. Ward J. M. (2010). Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system. Toxicol Pathol 38, 5S–81S.
71. Wakefield L. M. Roberts A. B. (2002). TGF-beta signaling: positive and negative effects on tumorigenesis. CurrOpin Genet Dev 12, 22–29.
72. Wallace K. Burt A. D. Wright M. C. (2008). Liver fibrosis Biochem J 411, 1–18.
73. Watanabe T. Niioka M. Hozawa S. Kameyama K. Hayashi T. Arai M. Ishikawa A. Maruyama K. Okazaki I. (2000). Gene expression of interstitial collagenase in both progressive and recovery phase of rat liver fibrosis induced by carbon tetrachloride. J Hepatol 33, 224–35.
74. Wolf J. C. Wolfe M. J. (2005). A brief overview of nonneoplastic hepatic toxicity in Fish. Toxicol Pathol 33, 75–85.
75. Yasuda M. Shimizu I. Shiba M. Ito S. (1999). Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats. Hepatology 29, 719–27.
76. Yoshiji H. Kuriyama S. Miyamoto Y. Thorgeirsson U. P. Gomez D. E. Kawata M. Yoshii J. Ikenaka Y. Noguchi R. Tsujinoue H. Nakatani T. Thorgeirsson S. S. Fukui H. (2000). Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model. Hepatology 32, 1248–54.
77. Zhang Z. Hu J. (2007). Development and validation of endogenous reference genes for expression profiling of medaka (Oryzias latipes) exposed to endocrine disrupting chemicals by quantitative real-time RT-PCR. Toxicol Sci 95, 356–68.